Doctor when can I drive? Braking response after knee arthroplasty: A systematic review & meta-analysis of brake reaction time.


Journal

The Knee
ISSN: 1873-5800
Titre abrégé: Knee
Pays: Netherlands
ID NLM: 9430798

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 01 09 2020
revised: 18 12 2020
accepted: 18 03 2021
pubmed: 5 5 2021
medline: 22 7 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

There is limited evidence available on return to driving for patients undergoing knee arthroplasty (KA). Primarily, surgeons have used brake reaction time as a surrogate measure of safe return to driving. The purpose of this study was to review existing literature and provide guidance on the recovery of braking performance following knee arthroplasty. A literature search was performed for prospective studies on driving after KA. Two reviewers screened citations for inclusion, assessed methodological quality, and extracted data. Values for total brake reaction-time (TBRT), movement-time (MT), reaction-time (RT), and braking-force (BF) were included for meta-analysis. Twelve studies with 368 subjects were identified. TBRT, RT, MT, and BF relative to preoperative baseline were assessed. Meta-analysis of TBRT showed a significant improvement from preoperative baseline at 3 months & 1 year (p = 0.003 & p = 0.0001). MT showed a significant increase at 2 and 4 weeks (p = 0.00001 & p = 0.03) before returning to no being significantly different at 6 weeks and beyond. In contrast RTs were noted to improve significantly 2 weeks (p = 0.006), 4 weeks (p = 0.03), and 1 year (p = 0.0002). Meta-analysis showed no significant difference in TBRT up until 3 months. RT increased significantly post-operatively suggesting it is not a reliable indicator. MT in contrast was significantly decreased post KA and may represent a more reliable measure of braking performance post KA. Surgeons should consider these recommendations and other patient factors that determine fitness to drive prior to advising their patients on a safe to return to driving.

Sections du résumé

BACKGROUND BACKGROUND
There is limited evidence available on return to driving for patients undergoing knee arthroplasty (KA). Primarily, surgeons have used brake reaction time as a surrogate measure of safe return to driving. The purpose of this study was to review existing literature and provide guidance on the recovery of braking performance following knee arthroplasty.
METHODS METHODS
A literature search was performed for prospective studies on driving after KA. Two reviewers screened citations for inclusion, assessed methodological quality, and extracted data. Values for total brake reaction-time (TBRT), movement-time (MT), reaction-time (RT), and braking-force (BF) were included for meta-analysis.
RESULTS RESULTS
Twelve studies with 368 subjects were identified. TBRT, RT, MT, and BF relative to preoperative baseline were assessed. Meta-analysis of TBRT showed a significant improvement from preoperative baseline at 3 months & 1 year (p = 0.003 & p = 0.0001). MT showed a significant increase at 2 and 4 weeks (p = 0.00001 & p = 0.03) before returning to no being significantly different at 6 weeks and beyond. In contrast RTs were noted to improve significantly 2 weeks (p = 0.006), 4 weeks (p = 0.03), and 1 year (p = 0.0002).
CONCLUSION CONCLUSIONS
Meta-analysis showed no significant difference in TBRT up until 3 months. RT increased significantly post-operatively suggesting it is not a reliable indicator. MT in contrast was significantly decreased post KA and may represent a more reliable measure of braking performance post KA. Surgeons should consider these recommendations and other patient factors that determine fitness to drive prior to advising their patients on a safe to return to driving.

Identifiants

pubmed: 33945981
pii: S0968-0160(21)00096-X
doi: 10.1016/j.knee.2021.03.013
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

214-240

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. Professor Pandit is a National Institute for Health Research (NIHR) Senior Investigator. Mr van Duren is a BRC-NIHR Academic Clinical Lecturer. The views expressed in this article are those of the author(s) and not necessarily those of the BRC, NIHR, or the Department of Health and Social Care.

Auteurs

Vasileios Giannoudis (V)

Leeds Orthopaedic & Trauma Sciences, School of Medicine, University of Leeds, United Kingdom.

Stephen Guy (S)

Bradford Royal Infirmary, United Kingdom.

Richard Romano (R)

Institute for Transport Studies, University of Leeds, United Kingdom.

Oliver Carsten (O)

Institute for Transport Studies, University of Leeds, United Kingdom.

Hemant Pandit (H)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom.

Bernard van Duren (B)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom. Electronic address: b.h.vanduren@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH